Richard G. Vincent - Apr 13, 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Chief Financial Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Apr 13, 2023
Transactions value $
$8,961
Form type
4
Date filed
4/14/2023, 06:00 AM
Previous filing
Feb 23, 2023
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $8.96K +30K +23.65% $0.30 157K Apr 13, 2023 Direct F1
holding ONCT Common Stock 4.53K Apr 13, 2023 By Family Trust
holding ONCT Common Stock 1.83K Apr 13, 2023 By Child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.2975 to $0.3000. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.